Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ: ZNTL · IEX Real-Time Price · USD

12.54

-0.17 (-1.34%)

At close: Apr 18, 2024, 4:00 PM

12.16

-0.38 (-3.03%)

After-hours: Apr 18, 2024, 4:06 PM EDT

Zentalis Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-292.19	-236.81	-158.73	-117.84	-45.66	-21.07
Depreciation & Amortization	1.39	1.43	0.54	0.16	0.11	0.05
Share-Based Compensation	54.82	46.84	35.74	23.15	0.62	0.31
Other Operating Activities	28.16	24.79	-31.65	7.71	5.79	-3.54
Operating Cash Flow	-207.82	-163.75	-154.09	-86.83	-39.14	-24.25
Capital Expenditures	-0.58	-2.55	-6.11	-0.76	-0.35	-0.23
Acquisitions	0	0	-14.32	0	0	0
Change in Investments	-43.88	-111.63	2.31	-284.07	0	0
Investing Cash Flow	-44.46	-114.18	-18.12	-284.83	-0.35	-0.23
Share Issuance / Repurchase	237.3	261.04	178.52	327.79	0	0.02
Other Financing Activities	-	-	-	32.65	81.83	9.46
Financing Cash Flow	237.3	261.04	178.52	360.44	81.83	9.47
Net Cash Flow	-14.98	-16.89	6.31	-11.22	42.34	-15.01
Free Cash Flow	-208.41	-166.3	-160.2	-87.58	-39.5	-24.48
Free Cash Flow Margin	-	-	-	-	-	-174842.86%
Free Cash Flow Per Share	-3.19	-3.15	-3.75	-3.12	-7.06	-4.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).